Brain dead, pregnant Atlanta nurse kept on life support to grow fetus gives birth to 1lb 13oz preemie named Chance: ‘He's just fighting'
Atlanta nurse Adriana Smith, 31, gave birth on June 13, three months premature via C-section, to a baby who weighs 1 pound 13 ounces and is currently in the neonatal intensive care unit at Emory University Hospital Midtown, according to local reports.
Smith's family members named the baby Chance and hope he'll get a fighting one himself.
Advertisement
5 Adriana Smith gave birth prematurely to a baby boy while brain-dead.
GoFundMe
'He's expected to be OK,' Smith's mother April Newkirk told local outlet 11 Alive.
'He's just fighting. We just want prayers for him. Just keep praying for him. He's here now.'
Advertisement
Newkirk previously told the press that the boy could be born with a variety of health problems and that the family is hoping his name brings him good fortune, according to reports.
As the grandmother prays for her grandbaby's tenuous health, Newkirk's daughter Adriana Smith, who turned 31 over the weekend, will finally be taken off of life support, the outlet reported.
'It's kind of hard, you know. It's hard to process,' she said tearfully.
5 Smith gave birth on June 13, three months premature via C-section, to a baby who weighs 1 pound 13 ounces and is currently in the neonatal intensive care unit at Emory University Hospital Midtown.
GoFundMe
Advertisement
Smith entered herself into Emory University Hospital, where she worked as a nurse, in February, with severe headaches. At the time, she was nine weeks pregnant.
She was discharged from the hospital with medication, but soon returned due to the intensity of the headaches.
A CT scan revealed multiple blood clots in her brain. Her health deteriorated while at the hospital, where, within hours, she was declared brain dead.
Smith was then moved to Emory Midtown, where doctors have utilized life-supporting technologies to keep her alive to be in compliance with the state of Georgia's LIFE Act, commonly referred to as the 'heartbeat bill.'
Advertisement
5 Smith entered herself into Emory University Hospital, where she worked as a nurse, in February, with severe headaches. At the time, she was nine weeks pregnant.
GoFundMe
That law bans any abortion after six weeks of pregnancy and provides fetuses with full legal rights and protections.
Newkirk said that doctors had told the family that Smith was being kept alive to maintain compliance with the law, according to The Guardian.
'We didn't have a choice or a say about it,' she said before Chance's birth. 'We want the baby. That's a part of my daughter. But the decision should have been left to us – not the state.'
Many believed that Chance would not survive due to the circumstances of his gestation, which further impelled critics of the pro-life policy.
5 Smith was then moved to Emory Midtown, where doctors have utilized life-supporting technologies to keep her alive to be in compliance with the state of Georgia's LIFE Act, commonly referred to as the 'heartbeat bill.'
GoFundMe
'The chances of there being a healthy newborn at the end of this is very, very small,' Steve Ralston, director of the maternal fetal medicine division at George Washington University, told The Washington Post.
The hospital's decision to keep Smith alive drew heavy criticism from pro-choice advocates who claimed the dizzying ethical conundrum and extreme heartache are a result of bad legislation.
Advertisement
'Because of Georgia's cruel abortion ban, Adriana Smith's family is living through a nightmare,' Reproductive Freedom For All President and CEO Mini Timmaraju said in a statement in May.
5 Smith gave birth at Emory University Hospital Midtown.
REUTERS
'Families deserve the freedom to make their own decision about their loved ones, and prolonging their suffering isn't just horrible policy; it's inhumane. Anti-abortion politicians, including Donald Trump and Governor Kemp, need to be held accountable,' the statement concluded.
State representatives also weighed in as the controversy reached its peak.
Advertisement
'This is not healthcare. This is sanctioned cruelty,' State Democrat Rep. Kim Schofield said in a statement.
The hospital has not publicly commented on the case, citing patient privacy laws.
Smith, who also has a 7-year-old son, was due to be taken off life support on Tuesday, 11 Alive reported.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
a day ago
- New York Post
Potentially fatal side effect of weight-loss drugs sparks new investigation
There's no doubt that GLP-1 drugs like Ozempic have been revolutionary — although the benefits do sometimes come with some unsightly downsides such as tooth decay, a droopy face or mouth, a saggy butt and hair loss. Then there are the more common side effects, like icky gastrointestinal issues, that are at best unpleasant. Now, a UK regulator is shining on a light on side effects that are much more serious — and even potentially deadly. 3 A UK regulator is taking a closer look at side effects from GLP-1 drugs that could be serious or even deadly. millaf – The country's Medicines and Healthcare products Regulatory Agency's (MHRA) Yellow Card scheme, the UK's official system for collecting and monitoring reports of suspected side effects or bad reactions to drugs and devices, has received nearly 400 reports of serious pancreas trouble from users of GLP‑1s. Acute pancreatitis is a sudden, often extremely painful inflammation of the pancreas that usually sends people to the hospital with severe abdominal pain, nausea and fever. While in many cases it's manageable, it can occasionally turn serious or even fatal if it triggers complications. In the UK alone, there have been at least ten deaths linked to this condition among users of GLP‑1 medications. Pamphlets on the popular weight loss drugs note that pancreatitis is an uncommon reaction that only affects one in 100 users — but the condition is deemed serious enough to warrant further investigation. 'Sometimes genes can influence the side‑effects an individual experiences when taking a medicine,' the MHRA told The Guardian, indicating they hope genetic screening might cut future risk. 3 Acute pancreatitis is a sudden, often extremely painful inflammation of the pancreas that usually sends people to the hospital with severe abdominal pain, nausea and fever. Studio Romantic – 'Patient safety is Lilly's top priority,' the pharmaceutical company that makes Mounjaro told The Guardian. 'We take reports regarding patient safety seriously and actively monitor, evaluate and report safety information for all our medicines.' 'We recommend that patients take these medications only for their approved indications and under the strict supervision of a healthcare professional, who can also advise on potential side effects,' Novo Nordisk, which produces Ozempic and Wegovy, told the outlet. 'We continuously collect safety data on our marketed GLP-1 medicines and work closely with the authorities to ensure patient safety. The benefit-risk profile of our GLP-1 medicines remains positive, and we welcome any new research that will improve our understanding of treatments for people living with chronic diseases.' 3 'We recommend that patients take these medications only for their approved indications and under the strict supervision of a healthcare professional, who can also advise on potential side effects,' Novo Nordisk, which produces Ozempic and Wegovy, told The Guardian. Ole – Although US regulators have not launched a formal investigation, this issue isn't limited to patients across the pond. A case study describes a 36-year-old woman in the US who 'developed acute pancreatitis within five weeks of exposure to semaglutide therapy.' The paper references a 'study involving 1,269 hospitalized cases of acute pancreatitis demonstrated that patients who were exposed to GLP-1 RAs within the last 30 days were over twice as likely to develop pancreatitis.' A 2024 analysis also found 6,751 reports of acute pancreatitis associated with GLP-1 drugs between 2005 to 2023. While US regulators like the FDA have not launched an investigation, they do require all GLP-1s to carry warnings about the risk of acute pancreatitis and are monitoring for this side effect.
USA Today
2 days ago
- USA Today
Former Houston Texans LB Bryan Braman battling rare form of cancer
Former Houston Texans linebacker Bryan Braman is battling an aggressive form of "life-threatening cancer," according to a GoFundMe set up in his benefit by William Jones. Braman, who spent three seasons with the Texans from 2011-2013, has undergone multiple surgeries while being treated in Seattle, according to a GoFundMe page set up to help him with expenses. Braman was diagnosed with cancer in February, according to his longtime agent, Sean Stellato. "He is required to have a 24-hour caregiver, but his insurance doesn't pay for housing for this program," the first GoFundMe update in February read. "He has no home currently as he has had to pay out of pocket for much of his treatment, and even sold his last vehicle to raise the money for the motel [for] this week." As of Saturday morning, the page has raised more than $53,000, including three donations from Braman's former Texans teammates. Three-time Defensive Player of the Year J.J. Watt donated $10,000. Pro Bowl left tackle Duane Brown donated $2,500 from Duane Brown while linebacker Brian Cushing donated $1,000. Several former Eagles teammates who have donated include Rasul Douglas, Brent Celek and Emmanuel Acho. Braman is currently undergoing treatment, which includes CAR T-cell Therapy. According to the American Cancer Society, the procedure is described as "a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells." "His cells did re-infuse themselves, and did in fact start reproducing within his bone marrow," the GoFundMe page wrote. "At first, the mass did start to shrink, but then the cancer started fighting back." Braman, 38, continues to fight and hopes to pull through with the support of former teammates and colleagues. "In the face of cancer, he embodies those qualities more than ever. If there is one person that I know that can beat cancer, it is Bryan Braman, who I have always considered family," Stellato told KPRC2 Sports. "He's in the fight of his life." Braman played seven seasons in the NFL from 2011 to 2017. During his three seasons with the Texans, he totaled 38 tackles and one sack.
NBC Sports
3 days ago
- NBC Sports
Former NFL LB Bryan Braman fights rare form of brain cancer
Former NFL linebacker Bryan Braman is fighting a rare and aggressive form of brain cancer, at the age of 38. Diagnosed in February, he has had multiple surgeries while undergoing treatment in Seattle. Via a GoFundMe page has been created to assist Braman with expenses arising from his treatment. As of this posted, more than $53,000 has been raised. Former teammate J.J. Watt has given $10,000, and other former teammates have contributed. Braman and Watt joined the Texans in the year — 2011. Braman was undrafted, but he made the team and remained in Houston for three seasons. He played the next four years with the Eagles. Braman capped his NFL career with a win over the Patriots in Super Bowl LII. En route to the championship, Braman blocked a punt in the divisional round win over the Falcons. Braman, who appeared in 97 career regular-season games, contributed mainly on special teams. One of his more memorable moments came in the final game of his rookie season, when he lost his helmet and still made the tackle on a punt return.
